In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1661 News Items found
A person reclining in a chair donates blood
Donating Bone Marrow and Stem Cells: The Process and What To Expect

Learn everything you need to know about donating bone marrow or blood stem cells and why it’s important to join a public registry.
Close-up of hand holding glass of red wine.
Does Drinking Alcohol Cause Cancer? Learn About the Risks

Learn more about the link between drinking alcohol and the risk of developing cancer.
Looking through a microscope at a tissue sample
MSK Research Highlights, December 29, 2023

New MSK research developed CAR T cells that target two acute myeloid leukemia-specific antigens; shed new light on a genetic element called LINE-1, opening the door to new treatments; identified a key regulator of blood stem cell fate; and found an immunotherapy technique using antibodies that target CD47 shows promise in mice.
Christine Mayr
Location, Location, Location: The Hidden Power of Intracellular Neighborhoods

New findings provide details about the hidden organization of the cytoplasm, showing it makes a big difference where in that cellular broth that messenger RNA (mRNA) get translated into proteins. The findings hold promise for increasing or altering the production of proteins in mRNA vaccines and therapies.
In the Clinic
MSK radiation oncologist and neuroblastoma expert Suzanne Wolden with a patient
Reduced Radiation for Neuroblastoma Could Lessen Children’s Side Effects Later

Learn how MSK doctors are exploring the use of less radiation in neuroblastoma treatment so children can avoid side effects.
a researcher holds a sign reading "Proud to be an MSK scientist"
Top Cancer Research Advances at MSK in 2023

Researchers at MSK pioneered many discoveries in 2023. Read about some of the most important findings.
Feature
Dr. Christopher Klebanoff
A New Type of Immunotherapy: MSK’s Christopher Klebanoff Is Fighting Cancer Cells From the Inside Out With T Cell Receptor (TCR) Therapy

Learn how MSK physician-scientist Christopher Klebanoff is working to bring immunotherapy to more patients, especially those with solid tumors.
MSK endometrial cancer specialists are seen: gynecological surgeon Carol Brown, MD; Carol Aghajanian, MD, Chief of the Gynecological Medical Oncology Service; medical oncologist Ying Liu, MD, MPH; and molecular geneticist Britta Weigelt, PhD.
Endometrial Cancer: New Insights Into a Deadly Disparity

Learn about new insights into endometrial cancer discovered by MSK experts, including why the growing rates of this cancer are even more dangerous for Black women.
Feature
Alicia Kalogeropoulos with her husband, Alex, at the beach.
Top Cancer Treatment Advances at MSK in 2023

Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2023. Read about some of the most important developments over the past year.
Feature
Dr. Miguel-Angel Perales
8 Reasons Why MSK Is a Leader in Stem Cell and Bone Marrow Transplants

The year 2023 marks the 50th anniversary of the first-ever transplant of bone marrow from a donor to a patient who was not related, which was performed at MSK. Here, Dr. Miguel-Angel Perales explains why MSK has continued to be a leader in the field of transplantation.